Literature DB >> 7688749

Characterization of integrin subunits, cellular adhesion and tumorgenicity of four human prostate cell lines.

C M Witkowski1, I Rabinovitz, R B Nagle, K S Affinito, A E Cress.   

Abstract

Cellular adhesion to extracellular matrix proteins via integrin molecules is a major factor in the process of invasion and metastasis of human tumor cells. Four human prostate cell lines were characterized according to the presence and quantity of integrin subunits, the ability of the cells to attach to extracellular substrates and the capacity of the cells to form tumors in severe combined immunodeficient (SCID) mice. All four human prostate cell lines expressed three to five integrins on their cell surfaces. The DU145, PC3 and 431P cells expressed primarily alpha 3, alpha 5, and alpha 6 integrin at similar levels. These cell lines expressed the subunits beta 1, beta 3, and beta 4 with beta 1 predominant. The DU145 cells preferred attachment to fibronectin, followed by laminin and vitronectin. Approximately 50%-60% of the binding of DU145 cells to fibronectin and laminin was dependent on the function of alpha 5 beta 1 and alpha 6 respectively. The cell line LNCaP differed in its low expression of the alpha 3 subunit, 95% of cellular adhesion to fibronectin and laminin being integrin-dependent and its inability to attach to vitronectin, in spite of surface expression of alpha v beta 3. All the cell lines except for LNCaP readily formed tumors within SCID mice and the expression of alpha 3, alpha 6, beta 1 and beta 4 integrin subunits was preserved in the resulting tumor tissue. The altered adhesion properties of the LNCaP cells may explain their altered tumorigenicity.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7688749     DOI: 10.1007/bf01215981

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  46 in total

1.  Changes in integrin receptors on oncogenically transformed cells.

Authors:  L C Plantefaber; R O Hynes
Journal:  Cell       Date:  1989-01-27       Impact factor: 41.582

2.  Purification and functional characterization of integrin alpha v beta 5. An adhesion receptor for vitronectin.

Authors:  J W Smith; D J Vestal; S V Irwin; T A Burke; D A Cheresh
Journal:  J Biol Chem       Date:  1990-07-05       Impact factor: 5.157

Review 3.  Reciprocal mesenchymal-epithelial interaction affecting prostate tumour growth and hormonal responsiveness.

Authors:  L W Chung; M E Gleave; J T Hsieh; S J Hong; H E Zhau
Journal:  Cancer Surv       Date:  1991

Review 4.  Fibroblasts are critical determinants in prostatic cancer growth and dissemination.

Authors:  L W Chung
Journal:  Cancer Metastasis Rev       Date:  1991-10       Impact factor: 9.264

5.  Multiple beta 1 chain integrins are receptors for invasin, a protein that promotes bacterial penetration into mammalian cells.

Authors:  R R Isberg; J M Leong
Journal:  Cell       Date:  1990-03-09       Impact factor: 41.582

6.  Transplantation of human prostatic carcinoma into nude mice in Matrigel.

Authors:  T G Pretlow; C M Delmoro; G G Dilley; C G Spadafora; T P Pretlow
Journal:  Cancer Res       Date:  1991-07-15       Impact factor: 12.701

7.  A novel fibronectin receptor with an unexpected subunit composition (alpha v beta 1).

Authors:  B E Vogel; G Tarone; F G Giancotti; J Gailit; E Ruoslahti
Journal:  J Biol Chem       Date:  1990-04-15       Impact factor: 5.157

8.  Development of skeletal metastasis by human prostate cancer in athymic nude mice.

Authors:  D H Shevrin; S C Kukreja; L Ghosh; T E Lad
Journal:  Clin Exp Metastasis       Date:  1988 Sep-Oct       Impact factor: 5.150

9.  Characterization of a novel differentiation antigen complex recognize by a monoclonal antibody (A-1A5): unique activation-specific molecular forms on stimulated T cells.

Authors:  M E Hemler; C F Ware; J L Strominger
Journal:  J Immunol       Date:  1983-07       Impact factor: 5.422

Review 10.  Integrin expression in malignant melanoma.

Authors:  R H Kramer; M Vu; Y F Cheng; D M Ramos
Journal:  Cancer Metastasis Rev       Date:  1991-05       Impact factor: 9.264

View more
  40 in total

Review 1.  The role of alpha(v)beta(3) in prostate cancer progression.

Authors:  Carlton R Cooper; Christopher H Chay; Kenneth J Pienta
Journal:  Neoplasia       Date:  2002 May-Jun       Impact factor: 5.715

2.  Identification of a novel structural variant of the alpha 6 integrin.

Authors:  T L Davis; I Rabinovitz; B W Futscher; M Schnölzer; F Burger; Y Liu; M Kulesz-Martin; A E Cress
Journal:  J Biol Chem       Date:  2001-05-18       Impact factor: 5.157

Review 3.  Integrin clipping: a novel adhesion switch?

Authors:  Manolis C Demetriou; Anne E Cress
Journal:  J Cell Biochem       Date:  2004-01-01       Impact factor: 4.429

4.  miR-138-Mediated Regulation of KINDLIN-2 Expression Modulates Sensitivity to Chemotherapeutics.

Authors:  Khalid Sossey-Alaoui; Edward F Plow
Journal:  Mol Cancer Res       Date:  2015-10-16       Impact factor: 5.852

5.  Integrin-dependent amplification of the G2 arrest induced by ionizing radiation.

Authors:  Celeste L Kremer; Monika Schmelz; Anne E Cress
Journal:  Prostate       Date:  2006-01-01       Impact factor: 4.104

6.  Serum CXCL13 positively correlates with prostatic disease, prostate-specific antigen and mediates prostate cancer cell invasion, integrin clustering and cell adhesion.

Authors:  Shailesh Singh; Rajesh Singh; Praveen K Sharma; Udai P Singh; Shesh N Rai; Leland W K Chung; Carlton R Cooper; Kristian R Novakovic; William E Grizzle; James W Lillard
Journal:  Cancer Lett       Date:  2009-04-17       Impact factor: 8.679

7.  Beta1C integrin in epithelial cells correlates with a nonproliferative phenotype: forced expression of beta1C inhibits prostate epithelial cell proliferation.

Authors:  M Fornaro; M Manzotti; G Tallini; A E Slear; S Bosari; E Ruoslahti; L R Languino
Journal:  Am J Pathol       Date:  1998-10       Impact factor: 4.307

8.  Prostate-derived Ets transcription factor (PDEF) is a potential prognostic marker in patients with prostate cancer.

Authors:  Ali Ghadersohi; Satish Sharma; Shaozeng Zhang; Rami G Azrak; Gregory E Wilding; Masoud H Manjili; Fengzhi Li
Journal:  Prostate       Date:  2011-01-12       Impact factor: 4.104

9.  Triiodothyronine Attenuates Prostate Cancer Progression Mediated by β-Adrenergic Stimulation.

Authors:  Evangelina Delgado-González; Ana Alicia Sánchez-Tusie; Giapsy Morales; Carmen Aceves; Brenda Anguiano
Journal:  Mol Med       Date:  2016-02-26       Impact factor: 6.354

10.  Rad9 protein contributes to prostate tumor progression by promoting cell migration and anoikis resistance.

Authors:  Constantinos G Broustas; Aiping Zhu; Howard B Lieberman
Journal:  J Biol Chem       Date:  2012-10-12       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.